CANCER FACT SHEETS: BREAST CANCER

Similar documents
CANCER FACT SHEETS: STOMACH CANCER

CANCER FACT SHEETS: LIVER CANCER

CANCER FACT SHEETS: ALL CANCERS EXCLUDING NON-MELANOMA SKIN CANCER

The epidemiology of tuberculosis

3.1 PHASE 2 OF THE GLOBAL PROJECT

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

511,000 (57% new cases) ~50,000 ~30,000

2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges

Measles and Rubella Global Update SAGE 19 October 2017

C R E A E. Consortium to Respond Effectively to the AIDS-TB Epidemic. An International Research Partnership

MAPS ON GLOBAL TOBACCO CONTROL POLICY DATA

Hepatitis B vaccination worldwide: Lessons learnt and the way forward

What can be done against XDR-TB?

Epidemiology of Hepatitis B in sub-saharan Africa. 7 February 2018 Yusuke Shimakawa, MD, PhD Institut Pasteur

宮村参考人提出資料 資料 2-2

Name of the presenter

Legend: No confirmed case With confirmed case No case based data

Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 31 March 2014

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 30 January 2014

Need for Chronic Viral Hepatitis Monitoring System

Measles cases MCV1 coverage MCV2 coverage

Legend: No confirmed case With confirmed case No case based data

Legend: No confirmed case With confirmed case No case based data

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2018, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 July 2014, WHO Western Pacific Region

HPV vaccine the global perspective

A Review of the Sutezolid (PNU ) Patent Landscape

Why still Polio Donato Greco ECDC polio consultant 14 April 2016

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 August 2014, WHO Western Pacific Region

East Carolina University Continuing Education Courses for Sustainability Symposium

Figure 1. Distribution of confirmed measles cases with rash onset 1 30 September 2014, WHO Western Pacific Region

WHO Rotavirus Vaccine Update Dr. Fatima Serhan WHO/FWC/IVB/EPI

Volume 10 Cervix Cancer Screening

Methodological issues in the use of anthropometry for evaluation of nutritional status

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 December 2014, WHO Western Pacific Region

TB epidemic and progress towards the Millennium Development Goals

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Polio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September

Latent tuberculosis infection

TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report

Global Rotavirus Surveillance Network

Progress under GAP Pillar 2 "Increase Production Capacity" Contribution of the WHO Technology Transfer Programme. Martin Friede

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Legend: No confirmed case With confirmed case No case based data

Esophageal cancer Study: China Story

Legend: No confirmed case With confirmed case** No case based data

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 March 2018, WHO Western Pacific Region

TUBERCULOSIS CONTROL WHO WESTERN PACIFIC REGION

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2017, WHO Western Pacific Region

Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net

Vaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO

Drug-resistant Tuberculosis

HPV Vaccination Global policy perspectives Vacuna VPH Perspectivas de la política de vacunación mundial

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

Drug resistance TB in People Living with HIV: research questions and priorities.

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

GLOBAL STATISTICS FACT SHEET 2015

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.

Maternal and Neonatal Tetanus Elimination by Yes, We Can! Global Immunization Meeting 18 th February 2009

GLOBAL HIV STATISTICS

EBOLA SITUATION REPORT

Cigarette Consumption in China ( ) Cigarette Consumption in Poland ( )

THE BASICS. WHAT IS THE RED RIBBON? The Red Ribbon is the international symbol of HIV and AIDS awareness. It stands for:

Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries

Cancer Incidence in Five Continents. Volume VIII

Building Global Palliative Care Building a Coalition for Advocacy

Global ProhrammeUpdate?

Module 1: HIV epidemiology, transmission and prevention

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

Improving accessibility to antiretroviral drugs: A south-south collaboration

Building Partnerships to Fight the Cancer Epidemic

National Breast Cancer Awareness Month. Media Handbook

Expanding access to injectable contraceptives

WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC,

HIV/AIDS in East Asia

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017

DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION

TB Intensive Minneapolis, Minnesota September 23-26, 2008

A Summary of Childhood Cancer Statistics in Australia,

WHO Emergency Risk Communication

Update on Polio Vaccine Supply

Burden of disease from the joint effects of household and ambient Air pollution for 2016

WHO Library Cataloguing-in-Publication Data. World health statistics 2011.

What will women s empowerment mean for men? Selected facts and figures to spark your thinking

Key Issue #1: Why Does Development Vary Among Countries? (299)

This summary outlines the burden of targeted diseases and program implementation outcomes in Rwanda. AFRICAN REGION LDC LIC

How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008

WORLD HEALTH ORGANIZATION. Control of neurocysticercosis

Access to treatment and disease burden

CERVICAL CANCER A GLOBAL PERSPECTIVE

FAST-TRACK COMMITMENTS TO END AIDS BY 2030

Sleep apnea devices Market Research Report- Global Forecast To 2022

This summary outlines the burden of targeted diseases and program implementation outcomes in Guinea-Bissau. AFRICAN REGION LIC

6. Gonococcal antimicrobial susceptibility

2. Treatment coverage: 3. Quality of care: 1. Access to diagnostic services:

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

Transcription:

CANCER FACT SHEETS: BREAST CANCER Estimated age-standardised rates (World) in the world (per 100 000) At a glance WHO South-East Asia Region More developed regions WHO African Region WHO Region of the Americas WHO Eastern Mediterranean Region Males Females Incidence Mortality Breast cancer is the second most common cancer overall, and by far the most common cancer in women. In 2012, worldwide, there are estimated to have been 1.67 million new cases (25% of all incident cancer cases). It is the most common cancer in women in both more and less developed regions, with slightly more 2012 cases estimated to have occurred in less developed regions (883 000 cases) than in more developed regions (794 000 cases). Incidence rates vary by a factor of nearly 4 across the world regions, with 2012 rates (per 100 000) ranging from 27 cases in central Africa and in eastern Asia to 96 cases in western Europe. WHO European Region Less developed regions WHO Western Pacific Region IARC Member State (24 countries) United States of America China India European Union (EU-28) 100 50 0 50 100 Breast cancer is the fifth most common cause of death from cancer overall, with 522 000 breast cancer deaths estimated to have occurred in 2012. Although it is still the most common cause of cancer death in women in less developed regions (with 324 000 deaths in 2012; 14.3% of all cancer deaths in women in less developed regions), it is now the second most common cause of cancer death (after lung cancer) in women in more developed regions (with 198 000 deaths in 2012; 15.4% of all cancer deaths in women in more developed regions). The variation in mortality rates across world regions is less than the variation in incidence rates, due to better survival in the (high-incidence) developed regions, with 2012 mortality rates (per 100 000 women) ranging from 6 deaths in eastern Asia to 20 deaths in western Africa.

Estimated incidence, mortality and prevalence (5 years) worlwide in 2012 Estimated numbers Cases Deaths 5-year-prev World 1 671 149 521 907 17 159 060 More developed regions 788 200 197 618 8 273 689 Less developed regions 882 949 324 289 8 885 371 WHO African Region 99 760 49 061 895 005 WHO Region of the Americas 408 281 92 058 4 114 742 WHO Eastern Mediterranean Region 99 284 42 228 732 587 WHO European Region 494 076 142 979 4 909 685 WHO South-East Asia Region 239 612 109 631 2 040 925 WHO Western Pacific Region 329 762 85 837 4 463 736 IARC Member State (24 countries) 934 832 256 832 9 401 981 United States of America 232 714 43 909 2 373 019 China 187 213 47 984 2 549 427 India 144 937 70 218 1 125 960 European Union (EU-28) 361 608 91 585 3 463 915

Estimated age-standardized rates (World) of incidence cases, females, breast cancer, worldwide in 2012 111.9 46.2 65.4 34.0 46.2 24.2 34.0 < 4.6 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC (http://gco.iarc.fr/today) World Health Organization International Agency for Research on Cancer 2016

Estimated age-standardized rates (World) of incidence cases, females, breast cancer, worldwide in 2012 * Regional data NORDCAN (www.ancr.nu) ECO (eco.iarc.fr) England: www.ons.gov.uk * Regional data CI5.iarc.fr * Regional data CI5.iarc.fr Australia : www.aih.gov.au New Zealand : wwww.health.govt.nz USA: seer.cancer.gov

Estimated age-standardized rates (World) of deaths, females, breast cancer, worldwide in 2012 28.4 15.2 18.2 13.1 15.2 10.1 13.1 < 1.8 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC (http://gco.iarc.fr/today) World Health Organization International Agency for Research on Cancer 2016

Estimated age-standardized rates (World) of deaths, females, breast cancer, worldwide in 2012 WHO (www.who.int/healthinfo/en/) WHO (www.who.int/healthinfo/en/) WHO (www.who.int/healthinfo/en/)